ARRIVENT BIOPHARMA INC. - COMMON STOCK
21.00
14-三月-25 16:45:00
15 分钟延时
股票
-0.75
-3.45%
今日范围
20.98 - 22.18
ISIN
N/A
来源
NASDAQ
-
ArriVent BioPharma Reports Full Year 2024 Financial Results
03 3月 2025 07:00:00 条件 Nasdaq GlobeNewswire
-
21 1月 2025 19:00:00 条件 Nasdaq GlobeNewswire
-
ArriVent BioPharma Reports Third Quarter 2024 Financial Results
14 11月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
14 8月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
12 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
05 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >